ArticleThe Journal of infectious diseases2020

Combination rhIL-15 and Anti-PD-L1 (Avelumab) Enhances HIVGag-Specific CD8 T-Cell Function.

Bruktawit A Goshu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.